Guardant Health Inc (GH)

NASDAQ
Currency in USD
36.78
-1.32(-3.46%)
Real-time Data
GH Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Trading near 52-week High
Fair Value
Day's Range
35.8339.29
52 wk Range
15.8139.29
Key Statistics
Edit
Prev. Close
38.1
Open
38.18
Day's Range
35.83-39.29
52 wk Range
15.81-39.29
Volume
845.53K
Average Volume (3m)
1.86M
1-Year Change
57.44%
Book Value / Share
-0.49
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GH Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
44.10
Upside
+19.90%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year
Show more

Guardant Health Company Profile

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Compare GH to Peers and Sector

Metrics to compare
GH
Peers
Sector
Relationship
P/E Ratio
−9.0x−3.5x−0.6x
PEG Ratio
1.67−0.040.00
Price/Book
−76.4x0.7x2.6x
Price / LTM Sales
6.6x1.0x3.1x
Upside (Analyst Target)
15.5%151.7%55.4%
Fair Value Upside
Unlock28.4%10.2%Unlock

Analyst Ratings

21 Buy
1 Hold
0 Sell
Ratings:
22 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 44.10

(+19.90% Upside)

Earnings

Latest Release
Nov 6, 2024
EPS / Forecast
-0.45 / -0.74
Revenue / Forecast
191.50M / 170.49M
EPS Revisions
Last 90 days

FAQ

What Is the Guardant Health (GH) Stock Price Today?

The Guardant Health stock price today is 36.78.

What Stock Exchange Does Guardant Health Trade On?

Guardant Health is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Guardant Health?

The stock symbol for Guardant Health is "GH."

What Is the Guardant Health Market Cap?

As of today, Guardant Health market cap is 4.50B.

What is Guardant Health Earnings Per Share?

The Guardant Health EPS is -4.22.

What Is the Next Guardant Health Earnings Date?

Guardant Health will release its next earnings report on 19 Feb 2025.

From a Technical Analysis Perspective, Is GH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.